Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares stood at 0.14 million during the last session, with the company’s beta value hitting 1.02. At the close of
During the last session, Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares were 0.38 million, with the beta value of the company hitting 0.80. At the end
Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares stood at 0.65 million during the last session, with the company’s beta value hitting 0.81. At the close of
In the last trading session, 0.16 million shares of the Quince Therapeutics Inc (NASDAQ:QNCX) were traded, and its beta was 0.82. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne